GLPwatch
Trials (2095)
Page 5 of 35.
- Effect of Tirzepatide on Brown Adipose Tissue in Obesity
- Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
- Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
- Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
- Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
- Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
- Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
- Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
- A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
- An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
- Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
- Risk Factors Affect Weight Loss Outcomes After Treatment.
- Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
- LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
- A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
- Feasibility of Semaglutide in Advanced Lung Disease
- The Microvascular Function of GLP-1 and Its Analogues
- Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
- Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
- Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
- A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
- A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
- Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
- Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves
- Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
- Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
- Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)
- A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
- Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
- Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
- A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
- Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
- Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
- Effect of Itopride on Semaglutide Gastroparesis
- A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
- A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
- The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal Gastroplication
- Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
- Trial for People With Established Type 2 Diabetes During Ramadan
- RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
- A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
- Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
- A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
- Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
- Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
- Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
- Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
- Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)
- Visualizing Beta Cells in Patients With a History of Gestational Diabetes
- Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
- PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
- Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
- Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1
- Efficacy of Mazdutide for Treating PCOS